Rainmed Medical (HKSE:02297) FCF Margin %: -385.76% (As of Dec. 2025)


HKSE:02297 Rainmed Medical Ltd HKSE:02297
49 GF Score
Price HK$0.22
GF Value HK$0.08
Valuation Significantly Overvalued
! 9 Warning Signs
View Full Analysis

What is Rainmed Medical FCF Margin %?

Rainmed Medical HKSE:02297 49 FCF Margin % is -385.76% as of Dec. 2025. GuruFocus rates HKSE:02297 with a GF Score™ of 49/100 and a GF Value™ of HK$0.08 (Significantly Overvalued). The stock has 9 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Rainmed Medical ranks worse than 91.8% on this metric.

FCF Margin % is calculated as Free Cash Flow divided by its Revenue. Rainmed Medical's Free Cash Flow for the six months ended in Dec. 2025 was HK$-37.38 Mil. Rainmed Medical's Revenue for the six months ended in Dec. 2025 was HK$9.69 Mil. Therefore, Rainmed Medical's FCF Margin % for the quarter that ended in Dec. 2025 was -385.76%.

As of today, Rainmed Medical's current FCF Yield % is -29.02%.

The historical rank and industry rank for Rainmed Medical's FCF Margin % or its related term are showing as below:

HKSE:02297' s FCF Margin % Range Over the Past 10 Years
Min: -424.95   Med: -245.02   Max: -28.93
Current: -424.75

During the past 6 years, the highest FCF Margin % of Rainmed Medical was -28.93%. The lowest was -424.95%. And the median was -245.02%.

HKSE:02297's FCF Margin % is ranked worse than
91.8% of 817 companies
in the Medical Devices & Instruments industry
Industry Median: -0.34 vs HKSE:02297: -424.75

Rainmed Medical FCF Margin % Related Terms

Rainmed Medical FCF Margin % Historical Data

* Premium members only.

The historical data trend for Rainmed Medical's FCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rainmed Medical FCF Margin % Chart

Rainmed Medical Annual Data
Trend Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
FCF Margin %
Get a 7-Day Free Trial -128.01 -168.70 -321.33 -346.78 -424.95

Rainmed Medical Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
FCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only -496.00 -213.44 -623.29 -457.98 -385.76

HKSE:02297 vs ABT, SYK, MDT: FCF Margin % Comparison

For the Medical Devices subindustry, Rainmed Medical's FCF Margin %, along with its competitors' market caps and FCF Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rainmed Medical FCF Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Rainmed Medical's FCF Margin % distribution charts can be found below:

* The bar in red indicates where Rainmed Medical's FCF Margin % falls into.


HKSE:02297
49GF Score
Rainmed Medical Ltd HKSE:02297
FCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Rainmed Medical FCF Margin % Calculation

FCF margin is the ratio of Free Cash Flow divided by net sales or Revenue, usually presented in percent.

Rainmed Medical's FCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-90.021/21.184
=-424.95 %

Rainmed Medical's FCF Margin for the quarter that ended in Dec. 2025 is calculated as

FCF Margin=Free Cash Flow (Q: Dec. 2025 )/Revenue (Q: Dec. 2025 )
=-37.38/9.69
=-385.76 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about FCF Margin % →
What does a FCF Margin % of -385.76% mean?
Rainmed Medical (HKSE:02297) has a FCF Margin % of -385.76% as of Dec. 2025. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Rainmed Medical and its competitors. According to the industry distribution chart, Rainmed Medical ranks #750 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 91.8%.
Is Rainmed Medical's FCF Margin % too high?
Rainmed Medical's current FCF Margin % is -385.76%. Based on the distribution chart, Rainmed Medical ranks #750 out of 817 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Rainmed Medical has a GF Score™ of 49/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Rainmed Medical's FCF Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Rainmed Medical ranks #750 out of 817 companies for FCF Margin %. This places Rainmed Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Margin % for a Medical Devices & Instruments company?
A good FCF Margin % depends on the Medical Devices & Instruments industry context. However, FCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Margin % mean?
A high FCF Margin % can signal that a stock is expensive relative to its fundamentals. Free cash flow margin is the ratio of total free cash flow to net sales. View historical data on Rainmed Medical and its competitors. Rainmed Medical's current FCF Margin % is -385.76%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rainmed Medical stock overvalued right now?
Based on GuruFocus' analysis, Rainmed Medical (HKSE:02297) is currently considered Significantly Overvalued. The stock's GF Value™ is HK$0.08, compared to a current price of HK$0.22 — trading 175% above its estimated fair value. The current FCF Margin % is -385.76%. Rainmed Medical's overall GF Score™ is 49/100 with 9 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Margin % calculated?
FCF Margin % is calculated from a company's financial statements. For Rainmed Medical (HKSE:02297), the current FCF Margin % is -385.76% as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Rainmed Medical (HKSE:02297) Overvalued in 2026?

Based on GuruFocus' analysis, Rainmed Medical stock appears to be overvalued. The current stock price of HK$0.22 is trading 175% above its estimated GF Value™ of HK$0.08. GuruFocus considers Rainmed Medical to be Significantly Overvalued.

Key valuation signals for HKSE:02297:

  • FCF Margin %: -385.76%
  • GF Value™: HK$0.08 vs. price of HK$0.22 (175% above fair value)
  • GF Score™: 49/100 with 9 warning signs

No single metric tells the full story. See the HKSE:02297 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Rainmed Medical Business Description

Address No. 99, Jinji Lake Avenue, Room NW-05-502, Building 31, Nanopolis Suzhou, Suzhou Industrial Park, Jiangsu Province, Suzhou, CHN, 215000
Rainmed Medical Ltd is focused on the design, development, and commercialization of coronary angiography-derived fractional flow reserve systems and coronary angiography-derived index of microcirculatory resistance systems. The company's core products, the caFFR system and the caIMR system, are medical devices used to evaluate the severity of myocardial ischemia arising from coronary artery stenosis and microvascular dysfunction, which are the underlying causes of coronary artery diseases (CAD). It operates in China and Other countries.
49GF Score

Get the complete analysis for HKSE:02297

FCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$0.22
Price
HK$0.08
GF Value